1-13 of 13
Authors: Ingrid Øra
Save search
Sort by
Journal Article

Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets

PDF
Elke Pfaff and others
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae185, https://doi.org/10.1093/noajnl/vdae185
Published: 08 November 2024
Journal Article

ETMR-28. EVALUATING THERAPEUTIC APPROACHES IN EMBRYONAL TUMORS WITH PLAGL1 AND PLAGL2 AMPLIFICATION AND UNRAVELING MOLECULAR PARALLELS IN EPIGENETICALLY RELATED TUMORS WITH PLAG1-ALTERATIONS

PDF
Michaela-Kristina Keck and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.198
Published: 18 June 2024
Journal Article

Ceramides: a potential cardiovascular biomarker in young adult childhood cancer survivors?

PDF
Olof Broberg and others
European Heart Journal Open, Volume 4, Issue 2, March 2024, oeae026, https://doi.org/10.1093/ehjopen/oeae026
Published: 04 April 2024
Journal Article

EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS

PDF
Audrey-Anne Lamoureux and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v117, https://doi.org/10.1093/neuonc/noad179.0442
Published: 10 November 2023
Journal Article

OTHR-04. DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM

PDF
Heike Peterziel and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i74–i75, https://doi.org/10.1093/neuonc/noad073.286
Published: 12 June 2023
Journal Article

CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

PDF
Sébastien Perreault and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii87, https://doi.org/10.1093/neuonc/noac209.327
Published: 14 November 2022
Journal Article

HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.

PDF
Audrey-Anne Lamoureux and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i61–i62, https://doi.org/10.1093/neuonc/noac079.226
Published: 03 June 2022
Journal Article

HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours

PDF
Karsten Nysom and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i64, https://doi.org/10.1093/neuonc/noac079.233
Published: 03 June 2022
Journal Article

Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors

PDF
François Doz and others
Neuro-Oncology, Volume 24, Issue 6, June 2022, Pages 997–1007, https://doi.org/10.1093/neuonc/noab274
Published: 27 November 2021
Journal Article

CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

PDF
François Doz and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi73–vi74, https://doi.org/10.1093/neuonc/noab196.283
Published: 12 November 2021
Journal Article

LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

PDF
Michael Fisher and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i32, https://doi.org/10.1093/neuonc/noab090.130
Published: 01 June 2021
Journal Article

RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

PDF
Sébastien Perreault and others
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i42, https://doi.org/10.1093/neuonc/noab090.168
Published: 01 June 2021
Journal Article

CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET

PDF
Sébastien Perreault and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii58, https://doi.org/10.1093/neuonc/noaa215.233
Published: 09 November 2020